Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   
Assessing the Impact of Childhood Interventions on Subsequent Drug Use Home
Assessing the Impact of Childhood Interventions
on Subsequent Drug Use
skip navigation About the Conference
Agenda

Agenda

Welcome   – Remarks by Richard Millstein, J.D. Deputy Director, National Institute on Drug Abuse, NIH
Remarks by Steven E. Hyman, M.D. Director, National Institute of Mental Health, NIH
    
Introduction and Overview – Meyer D. Glantz, Ph.D., National Institute on Drug Abuse

I. Basics

A research-based review of the epidemiology, neurobiology, and risk factors for comorbid psychiatric and drug use disorders in a developmental context.

Chair:  Naimah Weinberg, M.D., National Insitute on Drug Abuse

Presentation

Presenters

Introduction to Basics Kathleen R. Merikangas, Ph.D.
Yale University
Developmental Epidemiology Of Drug Abuse and Comorbidity Elizabeth Jane Costello, Ph.D.
Duke University
Neurobiology of Drug Effects
View in PowerPoint (Size: 1.17 MB)
Peter Kalivas, Ph.D.
Medical Univeristy of South Carolina
Developmental Neurobiology Of Drug Exposure Bryan Kolb, Ph.D.
University of Lethbridge
Alberta, Canada
Risk Factors and Trajectories For Drug Abuse Ralph E. Tarter, Ph.D.
University of Pittsburgh
Discussion Kathleen R. Merikangas, Ph.D., Chair
Yale University

Back to Top

II. Ongoing Treatment Studies

Treatment studies targeting various disorders, populations, and interventions, with drug abuse and other outcome measures.

Chair: Elizabeth Robertson, Ph.D., National Institute on Drug Abuse

Presentation Presenters

Presentation

Presenters

Introduction David J. Kolko, Ph.D.
University of Pittsburgh
Overview of Interventions Research Findings
View in PowerPoint (Size: 52 KB)
Barbara J. Burns, Ph.D.
Duke University
Fast Track Project Mark T. Greenberg, Ph.D.
Pennsylvania State University
Cognitive Behavior Therapy For Anxiety Disorders Philip C. Kendall, Ph.D.
Temple University
Massachusetts General Hospital ADHD Project Timothy Wilens, M.D.
Massachusetts General Hospital
Multimodal Treatment Study of Children with ADHD Peter S. Jensen, M.D.
Columbia University
Multisystemic Therapy Study
View in PowerPoint (Size: 66 KB)
Scott W. Henggeler, Ph.D.
Medical University of South Carolina
Panel Discussion – Research Implications

David J. Kolko, Ph.D., Chair

Barbara J. Burns, Ph.D.

Mark T. Greenberg, Ph.D.

Scott W. Henggeler, Ph.D.

Peter S. Jensen, M.D.

Philip C. Kendall, Ph.D.

Kathleen R. Merikangas, Ph.D.

Timothy Wilens, M.D.

Kenneth C. Winters, Ph.D.

Back to Top

III. Methodological Challenges

A. Measuring drug abuse and related risk factors

Chair: James D. Colliver, Ph.D., National Institute on Drug Abuse

Presentation Presenters

Presentation

Presenters

Introduction to Measurement Domains, Methods, and Instruments Robert Pandina, Ph.D.
Rutgers University
Drug Use Disorders Screening And Assessment Kenneth C. Winters, Ph.D.
University of Minnesota
Measuring Drug Use and Key Risk, Mediating and Moderating Factors
View in PowerPoint (Size: 71 KB)
Duncan Clark, Ph.D., M.D.
University of Pittsburgh
Panel Discussion

Robert Pandina, Ph.D., Chair

Duncan Clark, Ph.D., M.D.

Kenneth C. Winters, Ph.D.

B. Addressing Follow-up, Design, and Analysis Problems

Presentation

Presenters

Introduction to Followup, Design And Data Analysis Issues Robert Pandina, Ph.D.
Rutgers University
Dealing With Differential Attrition And Missing Data C. Henricks Brown, Ph.D.
University of South Florida
Nonrandom Designs, Appropriate Controls, and Limitations of Statistical Control
View in PowerPoint (Size: 86 KB)
Naihua Duan, Ph.D.
University of California, Los Angeles
Panel Discussion

Robert Pandina, Ph.D., Chair

C. Henricks Brown, Ph.D.

Naihua Duan, Ph.D.

Back to Top

IV. Research Implementation

Implementing studies on drug abuse and related behaviors: sample retention, ethical and legal matters, and scientific collaboration.

Chair: Vincent Smeriglio, Ph.D., National Institute on Drug Abuse

Presentation

Presenters

Ethical Considerations in Interventions Relevant to Mental Health and Drug Abuse
View in PowerPoint (Size: 254 KB)
Celia B. Fisher, Ph.D.
Fordham University
Working With High-Risk Populations: Sample Recruitment, Sample Retention, and Institutional Review Board Issues Nancy Day, Ph.D.
University of Pittsburgh
Conducting Multisite Collaborative Studies: Lessons Learned and Their Implications for Assessing the Impact of Childhood Interventions on Subsequent Drug Abuse
View in PowerPoint (Size: 35 KB)
Audrey Smith Rogers, Ph.D., M.P.H.
National Institute on Child Health and Human Development

Panel Discussion

Celia B. Fisher, Ph.D.

Nancy Day, Ph.D.

Audrey Smith Rogers, Ph.D., M.P.H.

V. Synthesis and Future Directions

Overview and Synthesis – Directions for Future Research

  • Philip C. Kendall, Ph.D., Temple University
  • Ronald C. Kessler, Ph.D., Harvard University Medical School

Back to Top



Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal